The Hospital Research Foundation Group Impact Report - Flipbook - Page 37
DEMENTIA
“It’s a wake-up call”
– Peter’s Alzheimer’s trial
Peter Hastings has seen firsthand what
dementia does to families.
drug Lecanemab as a way to slow down
the progression of Alzheimer’s.
His mother died with it. So did her
brothers and father. And now, with early
signs appearing in Peter’s own brain,
he’s determined to change the story for
the next generation.
“I don’t know if I’m on the placebo or
not, it might not benefit me, but it might
benefit my kids and my grandkids.
They’re the ones I’m doing it for.”
To give hope to families like Peter’s,
Diagnosed with pre-clinical Alzheimer’s, Peter
is part of an international clinical trial through
The Queen Elizabeth Hospital, testing the
please make a donation via (08) 8244
1100 or www.HospitalResearch.org.au
37
